Medication info
Hwanin Memantine Tablet 20mg (Memantine Hydrochloride)

Hwanin Memantine Tablet 20mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Hwanin Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP×3)]
Approval status
Active

MFDS item code 202401044 · Approved 2024.04.30 · Insurance code 657204180

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7) Administer 5mg once daily for 7 days. Week 2 (days 8–14) Administer 10mg once daily for 7 days. Week 3 (days 15–21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Hwanin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps alleviate cognitive decline in patients and improve daily living abilities. It plays a role in slowing the progression of symptoms and enhancing the patient's quality of life. It reduces damage to nerve cells and supports brain function, allowing for a more stable condition. Therefore, it is effectively used in the treatment of patients with moderate to severe Alzheimer's disease.

How to take

Adult dose

Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1–7) Administer 5mg once daily for 7 days. Week 2 (days 8–14) Administer 10mg once daily for 7 days. Week 3 (days 15–21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Because there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients with hypersensitivity to its components or those with severely impaired liver and kidney function. Caution is required when administering to patients with epilepsy or those with a history of seizures, as well as to patients taking certain NMDA antagonists, as this may increase the risk of side effects. Patients whose urinary pH is altered due to urinary conditions or changes in dietary habits, as well as those with uncontrolled heart disease or hypertension, should also be closely monitored during use. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur during the use of this medication. If these symptoms are severe or persist, consultation with a healthcare professional is necessary. Rarely, central nervous system adverse reactions such as mental confusion, hallucinations, and seizures may occur, so any unusual symptoms should be reported immediately. This medication may interact with other drugs, so if other medications are being taken, it is essential to inform the healthcare provider before using it. Women who are pregnant or nursing should avoid using this medication unless absolutely necessary, as its safety has not been established, and it is advisable to discontinue breastfeeding while taking this medicine. Use in children and adolescents under 18 years of age is not recommended as its safety and efficacy have not been confirmed. In cases of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, and immediate medical attention is required. This medication may affect the patient's reaction speed, so caution is necessary when driving or operating machinery. When storing, keep it out of reach of children and do not transfer it to other containers.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 37 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/embolism
  • shortness of breath
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • agitation
  • aggression
  • hallucination
  • gait disorder
  • vomiting
  • diarrhea
  • coma
  • double vision
  • agitation
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps preserve the medication's effectiveness for a longer duration.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP×3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.